3rd January 2014
Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")
Top Ten Equity Holdings - 31st December 2013
Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31st December 2013 the top ten equity holdings and the sector breakdown were as follows:
Top 10 Holdings |
% |
Novartis |
7.1% |
Eli Lilly |
6.6% |
AstraZeneca |
6.6% |
Merck & Co |
6.5% |
Roche Holding |
5.7% |
GlaxoSmithKline |
5.6% |
Pfizer |
5.5% |
Sanofi |
4.8% |
Abbvie Inc NPV |
4.1% |
Astellas Pharma |
3.7% |
Total |
56.2% |
Sector Exposure |
% |
Pharmaceuticals |
68.1% |
Health Care Equipment |
6.7% |
Specialized REITs |
5.1% |
Health Care Facilities |
4.8% |
Biotechnology |
4.8% |
Health Care Services |
3.0% |
Health Care Supplies |
2.5% |
Health Care Technology |
1.3% |
Life Sciences Tools & Services |
1.3% |
Health Care Distributors |
1.0% |
Managed Health Care |
0.7% |
Life & Health Insurance |
0.5% |
Cash |
0.3% |
Multi-line Insurance |
0.1% |
Total |
100.0% |
A copy of the entire portfolio as at 29th of November 2013 will be available to view shortly on the Company's website.
The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager. www.Polarcapitalhealthcaretrust.com
Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.